2022 InTouch Archive

December 17, 2022 [Topics: COVID-19 Updates (HHS Releases Long COVID Report, FDA Relaxes EUA Advertising Limitation, FDA Pauses EUA of Bebtelovimab), Addressing Pharmacy Deserts One Store at a Time, APhA Annual Meeting and Exposition, Indiana Regulatory Update, Federal Regulatory Update, Drug Approval News, FDA New Drug Approvals]

November 30, 2022 [Topics: COVID-19 Update (HHS to extend Public Health Emergency), OIG Telehealth Fraud Concerns, Pharmacy Times: Wellness is the Future of Pharmacy But is the Profession Prepared?, FDA Guidance on Compounding Certain Beta-Lactam Products, Indiana Regulatory Update, Federal Regulatory Update (Temporary Discretion for Clozapine REMS Requirements, USP <795> and <797>, Physician Fee Schedule Updates Vaccine Adminstration Payment for 2023)]

November 23, 2022 [Topics: COVID-19 Update (Advertising and Marketing Rules, Pharmacist Impact, Pharmacist prescribing antiviral treatment, FDA EUA for Anakinra Injection), NCPA Releases First Episode of "Show Me" Reality Series, CDC Releases Updates Opioid Prescribing Guidelines, Tricare Contract Advocacy Update, Indiana Regulatory Update, Federal Regulatory Update (Temporary Discretion for Clozapine REMS Requirements, USP <795> and <797>, Physician Fee Schedule Updates Vaccine Adminstration Payment for 2023)]

November 4, 2022 [Topics: COVID-19 Update (Oral antiviral toolkit), Vaccines Update (2023 childhood and adult vaccination schedule), Pharmacy-Based Medication Administration Services Summit, Flu Season is Here- Are You Ready for an Audit, Medicaid Announcees Statewide Uniform, Preferred Drug List, Federal Regulatory Update (Preterm birth drug, out-of-state distribution limits, compounded human drug products, standard MOU)]

October 25, 2022 [Topics: COVID-19 Updates (Most common symptom, winter surge, end of public health emergency preparation, dropping masking guidelines), Vaccines Update (Moderna and Pfizer EUA, Novavax booster), ADHD Medication Shortage, PBM reform (Tricare contract), Federal Regulatory Update (340B)]

October 15, 2022 [Special Edition Topics: SB1 takes effect September 15, 2022; Legal status of abortion in Indiana; Miscarriages and ectopic pregnancies; Abortion inducing drugs; Out of state providers prescribing abortion medication; Patient referral; Contraception products; HHS Guidance]

October 7, 2022  [Topics: COVID-19 updates (EUA amended for Moderna and Pfizer vaccine; Paxlovid; Vaccine likely to become annual); ADHD Medication Shortage; Monkeypox Vaccine; CDC annual influenza vaccine recommendations; Indiana Regulatory News; Ready for DCSA?; Part D enrollment; Federal regulatory update (OTC contraception; PA requirements in Medicare advantage; GFI 256; Human nonprescription drug labels; 340B; Insulin and vaccines in part D)]

September 9, 2022 [Topics: COVID-19 updates (The Next COVID-19 booster; Vaccine Coverage; Novavax vaccine; FDA Booster Authorization); ACIP Influenza Recommendations; APhA Delegate Selection; Indiana Regulatory News; New Drug Approvals; Federal regulatory update (Aspirin; Tubeless automated Insulin system; C2 Prescriptions; Discontinue CMNs and DIFs)]

August 26, 2022 [Topics: COVID-19 updates (Novavax vaccine; PHE extension; CDC guidance); IPA name change; TabulaRasa Health Care MedWise; Monkeypox; IHCP bulletins (Paxlovid claims; COVID-19 vaccines for children); Federal regulatory update (C2 prescription changes; therapeutic equivalence evaluations; pediatric influenza treatment)]

August 12, 2022 [Topics: COVID-19 updates (Novavax vaccine; Remdesivir recall; Paxlovid); SB 1 (abortion ban) summary; APhA Delegate Selection; IPA Federal Advocacy (Paxlovid reimbursement; PBM); July 2022 new drug approvals; Federal regulatory update (340B; NDC revisions; heart disease & stroke prevention resources)]

Our Mission:

To be the voice and advocate for the profession of pharmacy in Indiana.

Our Vision:

To lead the advancement of Indiana Pharmacy by promoting legislation and innovations that optimize patient care, safety, and the health of our communities.